Literature DB >> 6768883

Rhesus incompatibility and a survey of the care of rhesus negative pregnant women in one general practice.

G Lister.   

Abstract

I review some of the literature and developments in research concerning rhesus immunization and report on a small survey, carried out in a group practice with a list size of about 12,000, of women who were delivered during the first 10 months of 1977. There were 106 deliveries (including one set of twins), and 16 rhesus negative mothers (one of whom had the twins). Of 17 infants delivered to these mothers, eight were rhesus negative, seven rhesus positive, and two were not grouped. None of the mothers developed antibodies and all the rhesus negative mothers at risk received anti-D. However, the survey shows discrepancies between hospital and practice records and recommendations to improve this are suggested.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768883      PMCID: PMC2159395     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  5 in total

1.  Immunization of RhO(D)-negative secundigravidae whose first pregnancy was terminated by induced abortion.

Authors:  I Simonovits; G Bajtai; R Kellner; M Kerényl; L Rucz; R Szilvás; S Takács
Journal:  Haematologia (Budap)       Date:  1974

Review 2.  Practical clinical aspects of RH-prophylaxis.

Authors:  J T Queenan; J Schneider
Journal:  J Perinat Med       Date:  1973       Impact factor: 1.901

3.  Reduced severity of Rh-haemolytic disease after anti-D immunoglobulin.

Authors:  L A Derrick Tovey; A E Robinson
Journal:  Br Med J       Date:  1975-11-08

4.  The detection of anti-D in Rho (D)-negative infants born of Rho (D)-positive mothers.

Authors:  F W Bowen; M Renfield
Journal:  Pediatr Res       Date:  1976-04       Impact factor: 3.756

5.  Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding.

Authors:  J R Scott; A E Beer; L R Guy; M Liesch; G Elbert
Journal:  Obstet Gynecol       Date:  1977-01       Impact factor: 7.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.